Finding Answers, Demanding Justice

Hip implant failure: warning signs patients should not ignore

On Behalf of | Nov 19, 2026 | Medical Malpractice

Hip replacement surgery helps thousands of people regain mobility each year. Most implants are designed to last fifteen to twenty years or more. However, some devices fail early and cause serious harm. Knowing the warning signs may help you seek care before problems worsen.

Ongoing pain signals potential problems

Pain that returns months or years after surgery often indicates trouble. The discomfort may feel sharp, dull, or throbbing, and it often worsens with activity. New pain is different from normal post-surgical soreness. Patients generally should not experience increasing pain after the initial recovery period. Symptoms that persist or intensify need prompt medical review.

Mobility changes and physical limitations

Difficulty walking, climbing stairs, or standing may signal implant failure. The hip may feel unstable or give way without warning. Some patients notice a grinding sensation or hear clicking sounds during movement. Swelling around the joint, reduced range of motion, and inflammation in nearby tissue often accompany these symptoms and may appear gradually or suddenly.

Body-wide symptoms requiring urgent care

Fever, chills, or drainage from the surgical site may indicate infection. Metal-on-metal hip implants can release cobalt and chromium particles into the surrounding tissue and bloodstream, a condition known as metallosis, which may cause fatigue, chest pain, neurological changes, and other systemic symptoms. Federal law requires medical device manufacturers to warn patients about known risks through FDA-mandated labeling. Patients experiencing these symptoms should seek emergency care and document all medical visits carefully.

What Michigan patients should understand about their legal options

When symptoms point to device failure, understanding your legal options in Michigan requires knowing some important state and federal law considerations.

Michigan law creates a rebuttable presumption that an FDA-approved medical device is not defective. This presumption can be overcome if the manufacturer fraudulently misrepresented information to the FDA or if the device has since been withdrawn from the market. This is a meaningful threshold that distinguishes Michigan hip implant litigation from claims pursued in other states.

Federal law adds another layer of complexity. For certain Class III hip implants that received full premarket approval from the FDA, the U.S. Supreme Court’s decision in Riegel v. Medtronic, 552 U.S. 312 (2008), may limit some state law claims through federal preemption. Whether preemption applies depends on the specific device and the approval pathway it went through.

Medical device failures may result from design defects, manufacturing defects, or inadequate warnings about known risks. Patients may have legal options when defective implants cause harm, but those options depend heavily on the specific device, its FDA status, and the nature of the failure.

Speaking with a Michigan attorney can help you understand how Michigan law applies to your specific implant and situation, and whether the facts of your case may overcome the presumptions that apply.

Archives